The Impact of Intensive Exercise Therapy on Motivation and Continuation of Exercise in Patients with Type 2 Diabetes

The Impact of Intensive Exercise Therapy on Exercise Self-Efficacy and Adherence in Patients with Type 2 Diabetes: A Prospective Cohort Study - Type 2 Diabetes Exercise Therapy Adherence Study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000057399

Enrollment

Registered

2025-04-01

Start date

2025-03-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

During a multi-week hospital stay, intensive exercise therapy will be conducted as part of physical therapy. The program includes strength training (Borg Scale 14-16), aerobic exercise (Borg Scale 12-

s physical function and lifestyle history. 1.Emphasize that exercise therapy is as important as pharmacotherapy and dietary therapy in managing diabetes. If needed, explain the acute and chronic effe

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes hospitalized for diabetes education at Osaka Saiseikai Ibaraki Hospital.

Exclusion criteria

Exclusion criteria: Patients who suffer from excessive pain or motor paralysis that makes various motor function evaluations difficult. In addition, patients with an HDS-R score of 20 or below, whose accuracy in completing questionnaires is expected to be significantly reduced.

Design outcomes

Primary

Measure	Time frame
The Exercise Adherence Rating Scale (EARS) and the International Physical Activity Questionnaire (IPAQ) will be used to evaluate the continuity of exercise therapy. EARS will be assessed at discharge and 6 months after discharge, while IPAQ will be assessed at admission and 6 months after discharge.	—

Secondary

Measure	Time frame
At admission and discharge, patients' physical and mental functions will be evaluated using the Japanese version of the Self-Efficacy for Exercise Scale (SEE), the presence or absence of frailty (based on J-CHS criteria), the presence or absence of sarcopenia (based on AWGS2019), the presence or absence of locomotive syndrome, calf circumference, grip strength, 10-meter walking time, knee extension strength, grip strength (again), the two-step test, the Michigan Neuropathy Screening Instrument (MNSI), and ankle dorsiflexion range of motion.	—

Measure

Time frame

At admission and discharge, patients' physical and mental functions will be evaluated using the Japanese version of the Self-Efficacy for Exercise Scale (SEE), the presence or absence of frailty (based on J-CHS criteria), the presence or absence of sarcopenia (based on AWGS2019), the presence or absence of locomotive syndrome, calf circumference, grip strength, 10-meter walking time, knee extension strength, grip strength (again), the two-step test, the Michigan Neuropathy Screening Instrument (MNSI), and ankle dorsiflexion range of motion.

—

Countries

Japan

Contacts

Public ContactYuka Ito

Osaka Saiseikai Ibaraki Hospital Department of Rehabilitation Medicine

youcan.one@gmail.com072-622-8651

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026